Antibiotic Injection Franchise in Ahmedabad

Hospital Injection Supplier in Mumbai

Antibiotic Medicine Distributor in Delhi

Ticarcillin Injection Manufacturer in Bangalore

Pharma Injection Stockist in Hyderabad
Antibiotic Injection Exporter in Chandigarh

Home/Products /ticarcillin-3000mg-clavulanic-acid-100mg-injection

Ticarlin CV 3.1 Injection

Composition : Ticarcillin (3000mg) + Clavulanic Acid (100mg)

Dosage Form : Injection

Packaging Type : Vial

Packaging : 2 ml Dispo PACK

Price : ₹1/-

Ticarlin CV 3.1 Injection contains Ticarcillin and Clavulanic Acid, a combination antibiotic used for the treatment of severe bacterial infections. It is effective in managing respiratory tract, urinary tract, intra-abdominal, and soft tissue infections.

Ticarcillin works by inhibiting bacterial cell wall synthesis, while Clavulanic Acid acts as a beta-lactamase inhibitor, preventing antibiotic degradation and enhancing its effectiveness against resistant bacteria.

This injection is widely used in hospital and critical care settings due to its broad-spectrum antibacterial activity and reliability in treating complicated infections. It is often prescribed when resistance to standard antibiotics is observed.

With increasing demand for advanced antibiotic combinations and rising infection cases, this product offers strong market potential. Its hospital-based usage, consistent prescription demand, and wide therapeutic coverage make it a valuable option for business growth in the anti-infective segment.


Read More

About the Product

Ticarlin CV 3.1 Injection contains Ticarcillin and Clavulanic Acid, a combination antibiotic used for the treatment of severe bacterial infections. It is effective in managing respiratory tract, urinary tract, intra-abdominal, and soft tissue infections.

Ticarcillin works by inhibiting bacterial cell wall synthesis, while Clavulanic Acid acts as a beta-lactamase inhibitor, preventing antibiotic degradation and enhancing its effectiveness against resistant bacteria.

This injection is widely used in hospital and critical care settings due to its broad-spectrum antibacterial activity and reliability in treating complicated infections. It is often prescribed when resistance to standard antibiotics is observed.

With increasing demand for advanced antibiotic combinations and rising infection cases, this product offers strong market potential. Its hospital-based usage, consistent prescription demand, and wide therapeutic coverage make it a valuable option for business growth in the anti-infective segment.


Common side effects may include nausea, vomiting, diarrhea, and injection site reactions such as pain or swelling. Some patients may experience rash or allergic reactions. Rarely, severe hypersensitivity reactions, liver enzyme elevations, or blood-related abnormalities may occur.

Ticarlin CV 3.1 Injection (Ticarcillin 3000 mg + Clavulanic Acid 100 mg) is indicated for the treatment of severe bacterial infections, including lower respiratory tract infections, urinary tract infections, intra-abdominal infections, gynecological infections, skin and soft tissue infections, and bone and joint infections. It is effective against beta-lactamase–producing organisms due to the presence of clavulanic acid

This injection should be administered under strict medical supervision. Inform your doctor about any history of allergy to penicillins or cephalosporins. Dose adjustment may be required in patients with renal impairment. Complete the full prescribed course to prevent antibiotic resistance and ensure effective treatment.

Store in a cool, dry place below 25°C, protected from light and moisture. Keep out of reach of children. Use immediately after reconstitution as directed.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation